H.R. 10522
Companion Animal Protection Against Cruel Testing Act
Sponsor: Nicholas A. Langworthy
Official summary
Written by the Congressional Research Service.
Companion Animal Protection Against Cruel Testing Act
This bill prohibits the use of funds made available to covered federal agencies for any biomedical research activity involving a live dog or cat. Covered agencies are agencies or offices within the Department of Health and Human Services (HHS) that award, administer, or expend federal funds for biomedical research.
This prohibition also applies to activities that materially facilitate biomedical research involving a live dog or cat (e.g., salaries, facility maintenance, and administrative support primarily related to such research). It does not apply to transportation and rehousing of animals previously used in biomedical research or observational activities that do not involve alteration of an animal’s normal environment or medical care.
The prohibition applies to federal funds obligated or expended beginning 180 days after the bill is enacted. HHS may waive the prohibition in limited circumstances if necessary to respond to a specified emergency.
Recipients of funding from covered agencies must make reasonable efforts to transfer dogs and cats no longer needed for research to rescue organizations or other appropriate entities. Further, recipients may only euthanize an animal if a veterinarian has determined euthanasia is necessary for animal welfare or public safety.
If HHS determines that a recipient has violated a provision of the bill, it may withhold further funding to the recipient, recover funds expended in violation, and impose other administrative remedies.
Finally, the Government Accountability Office must report to Congress on the bill's implementation within three years after the bill takes effect.
Text of the bill
(a) Review required. The Comptroller General of the United States shall conduct an independent review of the implementation and administration of this Act.
(b) Scope of review. The review under subsection (a) shall evaluate—
(1) the effectiveness of the certification process;
(2) the adequacy of oversight and enforcement activities;
(3) the veterinary services provided to dogs and cats in biomedical research facilities;
(4) compliance by recipients of covered Federal agency funding;
(5) the administrative burden associated with implementation;
(6) the effectiveness of internal controls established by covered Federal agencies; and
(7) any recommendations for improving administration of this Act.
(c) Submission. Not later than 3 years after the effective date of this Act, the Comptroller General of the United States shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report describing the results of the review under subsection (a).